On February 8, 2018 Acorda Therapeutics, Inc. (Nasdaq: ACOR) reported that Ron Cohen, M.D., Acorda’s President and CEO, will present at the Leerink Global Healthcare Conference on Thursday, February 15 at 1:30pm EST (Press release, Acorda Therapeutics, FEB 8, 2018, View Source [SID1234523810]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A live audio webcast of the presentation can be accessed under "Investor Events" in the Investor section of the Acorda website at www.acorda.com, or you may use the link: